BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 38569602)

  • 1. Repurposing the diuretic benzamil as an anti-osteosarcoma agent that acts by suppressing integrin/FAK/STAT3 signalling and compromising mitochondrial function.
    Lin MC; Chen GY; Yu HH; Hsu PL; Lee CW; Cheng CC; Wu SY; Pan BS; Su BC
    Bone Joint Res; 2024 Apr; 13(4):157-168. PubMed ID: 38569602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
    Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
    BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
    Liu Y; Liu X; Yang S
    Biol Pharm Bull; 2021 Jun; 44(6):861-868. PubMed ID: 33828027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
    Dai G; Zheng D; Guo W; Yang J; Cheng AY
    Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
    Huang L; Huang Z; Lin W; Wang L; Zhu X; Chen X; Yang S; Lv C
    Int J Oncol; 2019 Jun; 54(6):1969-1980. PubMed ID: 31081055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3.
    Visavadiya NP; Keasey MP; Razskazovskiy V; Banerjee K; Jia C; Lovins C; Wright GL; Hagg T
    Cell Commun Signal; 2016 Dec; 14(1):32. PubMed ID: 27978828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic profiling reveals the mechanisms underlying the nephrotoxicity of methotrexate in children with acute lymphoblastic leukemia.
    Cheng Y; Chen Y; Zhao M; Wang M; Liu M; Zhao L
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30578. PubMed ID: 37449940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indocyanine green fluorescence imaging may detect tumour residuals during surgery for bone and soft-tissue tumours.
    Wang H; Ji T; Qu H; Yan T; Li D; Yang R; Tang X; Guo W
    Bone Joint J; 2023 May; 105-B(5):551-558. PubMed ID: 37121591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of integrin family in bone metabolism and tumor bone metastasis.
    Mao L; Wang L; Xu J; Zou J
    Cell Death Discov; 2023 Apr; 9(1):119. PubMed ID: 37037822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1-Mediated NRF2 Ubiquitination.
    Wang X; Zhou T; Yang X; Cao X; Jin G; Zhang P; Guo J; Rong K; Li B; Hu Y; Liu K; Ma P; Qin A; Zhao J
    Adv Sci (Weinh); 2023 May; 10(14):e2204438. PubMed ID: 36965071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective and renoprotective effects of venlafaxine on cisplatin-induced cardiotoxicity and nephrotoxicity in rats.
    Ali MIM; Imbaby S; Arafat HEK; Maher SA; Kolieb E; Ali SM
    Life Sci; 2023 May; 320():121561. PubMed ID: 36898429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiodynamic therapy with acridine orange local administration as a new treatment option for primary and secondary bone tumours.
    Matsuyama Y; Nakamura T; Yoshida K; Hagi T; Iino T; Asanuma K; Sudo A
    Bone Joint Res; 2022 Oct; 11(10):715-722. PubMed ID: 36214462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin and Therapies of Osteosarcoma.
    Moukengue B; Lallier M; Marchandet L; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884563
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.